INTRODUCTION
Analysis of the generation, function and long-term persistence of effector and memory T lymphocytes has been of fundamental importance to our understanding of protective immunity and to improve therapeutic vaccine strategies. Following TCR triggering, naive T cell precursors differentiate into antigen-experienced CD8 pos T lymphocytes, forming highly heterogeneous memory-and effector-like subpopulations based on their phenotype, function and anatomic location. [1] [2] [3] During T cell differentiation, stochastic events involve a set of modifications of multiple gene expressions inducing drastic changes in the cell and thus sustaining variability among the antigen-primed subpopulations. A powerful approach to explore the biological basis underlying differentiation of memory-and effector-like T cell subsets relies on molecular gene signature analyses using DNA microarrays. For instance, gene expression profiling led to the identification of memory-and effector-associated gene expression markers defining distinct functional properties of memory progenitor and terminal effector CD8 pos T cells, [4] [5] [6] and provided new insights in the progressive generation of those subsets during acute viral infection. 7, 8 Genome-wide analysis further revealed a gene expression program diversion between CD4 pos and CD8 pos T cells at early stages of differentiation, contrasting with the similar molecular profiles found as cells reach later differentiation stages. 9 Moreover, functional cell exhaustion was associated with numerous molecular alterations in virus-specific T cells from chronic infections, 10 as well as in tumor-specific T cells from melanoma patient metastases.
11
A major limitation of gene microarrays lies in the fact that the resulting data only determine the average gene expression within a given cell population, thus masking the cell-to-cell variations potentially associated with different cellular functions or outcomes. 12 In order to obtain accurate gene expression patterns among quasihomogenous cell populations, there arises a need for single-cell analysis providing the highest resolution. In recent years, major efforts have been made to develop precise measurement of single-cell gene expression states in various biological models. [13] [14] [15] [16] In particular, Peixoto, Rocha and colleagues 17 For an in-depth monitoring of antigen-specific T cell responses, a key endpoint is to relate the expression of specific gene patterns to a distinct cellular phenotype. As such, single-cell gene expression profiling can provide a tight correlation between specific cell surface markers and CD8 pos T cell functional properties. 18 Specifically it was shown, that each memory-and effector-like CD8 pos T cell subset displayed a unique pattern of gene expression, with the progressive up-regulation of multiple effector mediators by the same cell along cell differentiation. 18 Cellular immune responses generated following therapeutic vaccines have also been described as highly diverse in terms of phenotype and functionality. 19 Recently Flatz and colleagues identified previously unrecognized subsets of CD8 pos T cells based upon analysis of gene-expression patterns within single cells and showed that they were differentially induced by different vaccines. 20 These studies emphasize the strong need to delineate the qualitative attributes of vaccine-induced CD8 pos T cell responses, not only at the phenotypic/functional levels but as well by defining the genetic signatures of single cells.
In the present study, we investigated the direct ex vivo properties of individual virusand tumor-specific CD8 pos T cells from healthy donors and from melanoma patients.
The latter had been vaccinated with low dose of either the natural or the analog modified Melan-A MART-1
26-35 peptide, mixed with CpG 7909 and Incomplete
Freund's adjuvant (IFA). 21 Previously, we have shown that natural peptide induced T cells, which had enhanced overall functionality and increased capacity to recognize tumor cells compared to T cells stimulated by the analog peptide. 21 Recently, we applied a modified RT-PCR protocol for direct ex vivo single T cell analysis, 22, 23 and found that non-dominant CD8 pos T cell clonotypes showed similar activation and differentiation as their dominant counterparts following natural peptide vaccination. 24 Here we extended the highly sensitive and specific single-cell approach to the analysis of multiple memory/homing-(CD27, IL7R, EOMES, CXCR3, and CCR5) and effector-(IFNG, KLRD1, PRF1, and GZMB) associated genes, which allowed us to detect qualitative differences within individual T cells after vaccination with natural versus analog peptide. Our data revealed a vast co-expression of memory/homing-and effector-related genes in T cells induced by vaccination with natural peptide, similar to protective CMV-specific T cells, thus suggesting a higher degree of functional diversity which may be important for mounting efficient responses to pathogens or tumors.
MATERIALS AND METHODS

Ethics statement
The clinical studies were designed and conducted according to the relevant regulatory standards, and approved by (i) the ethical commission of the University of Lausanne (Lausanne, Switzerland), (ii) the Protocol Review Committee of the Ludwig Institute for Cancer Research (New York, USA), and (iii) Swissmedic (Bern, Switzerland).
Patient recruitment, study procedures and blood withdrawal from patients and healthy donors were done upon written informed consent.
Patients and vaccination protocol
Four HLA-A*0201-positive patients with stage III/IV metastatic melanoma were included in a phase I clinical trial (LUD-00-018; www.clinicaltrials.gov, 
Direct ex vivo in-well cell lysis, and reverse transcription (RT)
Prior to FACS sorting, 10 ml of "Lysis buffer" was prepared using 9.22 ml RNAse free water molecular biology grade (AppliChem, Darmstadt, Germany), 400 µl of 0.1 M DTT (AppliChem), 80 µl of 10 mg/ml tRNA (Roche Pharma, Reinach, Switzerland), 300 µl of 100% Triton X-100 (Sigma-Aldrich, Buchs, Switzerland) and stored in 1 ml aliquots at -20°C till further use. The "5X RT buffer" was prepared using 12. Following ex vivo flow cytometry sorting, the plates were covered with a plastic adhesive cover and incubated at 37°C for 1 hour followed by a quick chill on ice.
This allowed a direct ex vivo in-well cell lysis and reverse transcription to cDNA. The plates were centrifuged at 1500 rpm for 1 min and transferred overnight to -80°C.
The next day, the plates were thawed, and the content of each well was transferred to 0.5 ml Eppendorf tubes. The tubes were placed at 90°C for 3 min to heat-inactivate the MMLV-RT enzyme, chilled on ice for 5 min and stored at -80°C until further use.
Global cDNA amplification
This procedure required a purification step (cDNA precipitation) followed by the addition of a homopolymer (dA) sequence to the 3'-OH end of the cDNA. Global cDNA amplification was then carried out using a single modified 61-mer oligo-(dT)
primer as adapted from Brady and Iscove 27 and Sauvageau et al. 28 cDNA precipitation: cDNA (from each tube stored at -80°C) was precipitated For specific gene expression analysis, we carefully designed our specific primers in such a way that they are usually located within the first 1000 bp upstream of the 3'-poly(dA) end of the mRNA sequence, and whenever possible inter-exonic, thus excluding genomic DNA amplification. We used the following primers: GAPDH: 5'-GGACCTGACCTGCCGTCTAG-3'; rev-5'-CCACCACCCTGTTGCTGTAG-3', β2 
TCR Vβ chain repertoire and clonotype analysis
TCR BV repertoire analysis or CDR3 spectratyping was performed as described previously. 29, 30 Briefly, pools of the equivalent of 50 cells were subjected to individual PCR in non-saturating conditions using a set of previously validated fluorescent-labeled forward primers specific for the 22 TCR BV subfamilies and one unlabeled reverse primer specific for the constant region of the β chain of the TCR. 31 This analysis represented a screening step. Once positive TCR BV subfamilies were identified, the following step consisted in subjecting each individually generated single-cell cDNA sample, and in parallel in vitro generated T cell clone to TCR BV PCRs. Separation and detection of amplified fragments containing the entire CDR3 segment was performed in the presence of fluorescent size markers on an ABI PRISM 310 Genetic Analyzer (AppliedBiosystems/Life Technologies Corporation, Zug, Switzerland) and data were analyzed with GeneScan 3.7.1 (AppliedBiosystems).
In the last step, PCR products of interest were directly purified and sequenced with the reverse primer (Fasteris SA, Geneva, Switzerland). Clonotypic primers for several CDR3 sequences were validated and used in clonotypic PCR for determination of clonotype frequencies as previously reported. 29, 30 All direct ex vivo single-cell and in vitro T cell clone cDNA samples were processed with the same rigorous approach to allow direct comparison among individuals and subsets.
Enzyme Linked Immunospot (Elispot) assay
To evaluate the ex vivo functional potential of tumor-specific T cells from vaccinated melanoma patients, IFN-γ Elispot assays were performed as described. 25 
Chromium release and target cell killing assays
Tumor-specific T cell clones were generated in vitro from four patients with melanoma following analog/ELA (n = 2) or natural/EAA (n = 2) peptide vaccination.
Lytic activity and antigen recognition was assessed functionally in 4-hour 
Statistical analyses
For quantitative comparison, linear regression analysis with 95% confidence intervals or two-tailed unpaired t test were performed with Prism 5.0 (La Jolla, California, USA), while one-way ANOVA test was performed by SPSS statistical version 19
(IBM, Chicago, USA). Co-expression pie charts were compared with each other using 10'000 permutations calculated with the Software SPICE 5.2 (NIH, Bethesda, USA).
RESULTS
Global cDNA amplification and validation of single-cell gene expression analysis
Following FACS-sorting of CD8 pos T cell subsets of interest (bulk or antigen-specific cells), single cells were directly lysed in-well before reverse transcription of mRNA to cDNA, and subsequent global amplification of total cDNA (Fig. 1) . The basic principle of this approach required that the target cellular cDNA be flanked by known sequences to which the amplification primers can anneal and initiate polymerization.
As such, the reverse transcription was completed using an oligo-(dT) primer that annealed to the poly(A) tail present at the 3' end of most mRNA molecules ( Fig. 1A; step 2). Next, a homopolymer (dA) sequence was added to the 3'-OH end of the cDNA using terminal deoxynucleotidyl transferase ( Fig. 1A; step 3 ). Global PCR amplification of the (dA)/(dT) flanked cDNAs was then carried out using a single 61-mer modified oligo-(dT) primer, as previously described by Brady and Iscove. 27 Specifically, priming of the cDNA during global PCR amplification was initiated via annealing of the (dT) region of this modified oligo-(dT) primer to the poly(dA) regions present at the 3' termini of the cDNA molecules ( Fig. 1A ; step 4). Since our approach uses oligo-(dT) based mRNA amplification, the only pre-requisite for the present technique is the careful design of primers such that they fall within the 1000 bp from the 3' end of mRNA. The efficiency of globally amplified cDNA from single CD8 pos T cells, also termed cDNA plus ( Fig. 1A ; step 5), was then analyzed for the expression of housekeeping genes like glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and beta-2-microglobulin (B2M) by semi-quantitative PCR. This represents a pre-screening step allowing selecting for positive GAPDH and/or B2M single-cell samples which will be further subjected to specific gene expression PCRs.
The average efficiency of > 2400 single cells analyzed was close to 80% and 90% using GAPDH and B2M, respectively (Fig. 1B) We next determined the specificity of the single-cell approach by assessing the expression of a panel of genes known to be differentially expressed in the naive CD8 pos T cell subset compared to the EMRA/effector differentiated subset (Fig. 2B ).
As expected, most of the naive T cell cDNA plus samples yielded detectable expression of CCR7, CD27 (a member of the TNF-receptor superfamily) and IL7R (the cytokine receptor IL-7Rα). In sharp contrast, these mRNA transcripts were rarely found in the EMRA/effector T cells, which instead contained significant levels of mRNA coding The TCR clonotype repertoire analysis of directly ex vivo sorted single tumor-and virus-specific T cells was first compared with that of single T cells generated by in vitro limiting dilution cultures, which has long been the method of choice for assessing TCR BV gene segment usage. 19 Despite a large usage of the 22 different TCR BV families, in line with our previous reports, 29, 30 we observed highly similar proportions of TCR BV family usage (Fig. 3A) and of individual TCR clonotype signatures ( Fig. 3B ) with both the direct ex vivo single-cell and the in vitro T cell cloning approaches. In particular, the single-cell analysis confirmed that TCR β-chain repertoires were broader after vaccination with natural than analog peptide. 29 Moreover, the EBV-specific TCR repertoire showed a preferential usage of TCR BV2 and BV4 gene segments with a wider variety of T cell clonotypes as compared to the restricted CMV-specific TCR β-chain repertoire. 30 Remarkably, the relative proportions of dominant T cell clonotypes, and to a lesser extent of sub-dominant clonotypes (with frequencies < 20%), were found to be very similar using either of the two techniques, resulting in a high correlation coefficient (Fig. 3C) peptide, comparable to that of protective T cell responses specific for CMV (Fig.   4A ). The proportion of "early-differentiated" CD28 pos T cells was maintained after peptide vaccination and was very similar between tumor-and virus-specific T cell responses.
In line with our previous reports, 21, 24 (Fig. 4C) . In contrast, most of tumor-specific T cell clones derived from the differentiated "effector-like" EM28 neg subset showed similar efficient lysis capacity, irrespectively of the peptide used for vaccination.
Extended co-expression of memory/homing-and effector-associated mRNA transcripts in single tumor-specific T cells induced by natural peptide vaccination
The powerful single-cell based approach enabled the assessment of expression of memory-and effector-related gene patterns from individual tumor-and virus-specific Fig. 4D and 4E) . Interestingly, EM28 pos EBV-specific T cells had the highest expression of memory/homing-related genes (Fig. 4D) , which contrasted to relatively low effector-gene expression (Fig. 4E ), in agreement with our previous reports. 24, 30 T cell responses induced by the natural/EAA peptide vaccine triggered memory/homing-associated gene expression patterns that were in between that of persistent EBV and analog/ELA peptide vaccine-induced T cells (Fig. 4D, left panel). Specifically, we observed significantly enhanced expression of CD27, CCR5
and the transcription factor EOMES within those T cells, compared to tumor-specific T cells following analog peptide vaccination. Importantly, a large proportion of the natural peptide vaccine-induced T cells expressed as well IFNG, KLRD1 (CD94), PRF1 and GZMB mRNA transcripts (Fig. 4E) , even in the less differentiated EM28 pos T cell compartment where the difference to the analog peptide induced T cells was statistically significant (Fig. 4E, left panel) .
Subsequently we analyzed the gene expression polyfunctionality as well as the heterogeneity of co-expression patterns of either memory/homing-or effectorassociated genes along cell differentiation (Fig. 5) . We found that vaccination with the analog/ELA peptide induced T cells with only limited co-expression, particularly for effector-associated genes in the early-differentiated EM28 pos subset (Fig. 5A) , and for memory/homing-associated genes in the late-differentiated EM28 neg /EMRA subsets (Fig. 5B ). These data are in sharp contrast to the single T cells induced by vaccination with the natural/EAA peptide, showing impressive gene expression polyfunctionality and co-expression variability of memory/homing-and of effectorassociated transcripts (up to 3/4 co-expressing genes). These co-expression patterns were preferentially found in the early-differentiated subset, and resembled those observed in protective CMV-specific T cells (Fig. 5A) . These findings indicate a differential process of cell differentiation following natural versus analog peptide vaccination, and show that the peptide used for vaccination determines the functional properties of individual tumor-specific T cells.
Natural peptide vaccination induced highly diverse individual T cells co-expressing multiple different memory/homing and effector gene patterns directly ex vivo
To assess the gene expression diversity among vaccine-induced T cells, we analyzed the distributions of tumor-and virus-specific T cells depending on their simultaneous co-expression of both memory/homing-and effector-associated gene transcripts.
Single T cells with all possible combinations of gene expression were plotted on three-dimensional matrix ( In contrast, analog/ELA peptide vaccine-induced T cells showed distinct memory/homing and effector-related gene co-expression patterns that were highly dependent on the differentiation stage (Fig. 6A , left panel), in agreement with the above-described results (Fig. 4 and Fig. 5 ). The early-differentiated EM28 pos subset primarily expressed memory/homing-associated transcripts, while the latedifferentiated EM28 neg cells mostly expressed effector-associated genes (up to 4 coexpressing transcripts) with only rare memory/homing-gene co-expression (up to 1-2 co-expressing transcripts). Finally, EBV-and CMV-specific T cells displayed memory/effector gene-co-expression patterns that placed them in between those observed for the natural and analog peptide vaccination induced T cells (Fig. 6B) .
Version 05.05.2012 Heterogeneity and co-expression of memory/homing and effector gene transcripts by tumor-and virus-specific T cell clonotypes
We recently reported a progressive restriction in the TCR BV/CDR3 diversity along cell differentiation (from EM28 pos to EM28 neg ). 24 T cell receptor (TCR) clonotype mapping revealed preferential selection and expansion of co-dominant T cell clonotypes, which made up between 50 to 60% of the differentiated "effector" T cells, but only 25% on average of the early-differentiated EM28 pos cells, mostly composed of non-dominant clonotypes. A striking observation was that tumorreactive T cell responses were in several patients dominated by individual clones, 33, 41 such as for example BV17.1 clonotype for patient LAU 618 or BV13.1 clonotype for patient LAU 1013 (Fig. 7) . This process occurred irrespective of whether natural or analog peptide was used for vaccination, and resembled that observed in EBV and CMV specific T cells. 30 Here we extended these analyses by assessing the direct ex vivo co-expression patterns of memory/homing-and effector-associated genes within the dominant T cell clonotypes that were selected with advanced differentiation, i.e. clonotypes found in both EM28 pos and EM28 neg subsets, compared to those that were not (Fig. 7) . The memory/homing and effector gene co-expression profiles of all dominant EM28 pos T cell clonotypes (Fig. 7A ) largely overlapped with those of the corresponding earlydifferentiated EM28 pos subset (Fig. 5A ). For example, BV13.1 clonotype induced by the natural/EAA peptide vaccination (from patient LAU 1013) was highly polyfunctional, with > 3 co-expressing memory/homing and/or effector genes. In contrast, BV17.1, BV3.1 and BV13.2 clonotypes from patient LAU 618 vaccinated with the analog/ELA peptide were globally less polyfunctional (Fig. 7A ). In the differentiated EM28 neg subset, all selected clonotypes showed reduced memory/homing-related gene co-expression, while maintaining or further acquiring effector-mediated gene co-expression (Fig. 7B) .
Importantly, the gene profiles of the EM28 pos T cell clonotypes that were highly selected with differentiation were more polyfunctional (co-expressing ≥ 2 memory/homing-or effector-associated genes) compared to those that were not selected or remained at low frequencies (Fig. 7A) . Indeed, many of the unselected of cell lysis and cDNA synthesis in a single-step procedure, followed by a modified PCR protocol that relies on the detection of specific cDNAs after global amplification of expressed mRNAs 22, 23 (Fig. 1) . This method yielded sufficient cDNA from as few as five cells, which allowed us to follow tumor-specific T cells before and after therapeutic peptide vaccination, 33, 41 as well as EBV-and CMV-specific T cells from healthy individuals over time. 30 Recently, we have optimized the above-described strategy of global cDNA amplification at the single-cell level for direct ex vivo monitoring of gene expression profiles 24 ( Fig. 2 and Fig. 4 ). Other methods have been documented to quantify the gene expression profile of a single-cell, all with their own uses, advantages and drawbacks. [42] [43] [44] [45] [46] Without contesting the validity and specificity of these techniques, we believe that our approach has the added advantages of practicality, low-cost and adaptability. By utilizing standard biological techniques (reverse transcription and semi-quantitative PCR), this single-cell method is affordable, as it does not require the engineering of novel microfluidic platforms 14 or the assistance of robotic technologies, except for an efficient sorting facility.
Nonetheless the implementation of automated steps is warranted to minimize sample manipulation, which may lead to contamination and loss of material.
Furthermore, our method does not require pre-customization of genes for selective amplification and therefore is completely flexible regarding the genes analyzed. Each PCR needs only small volumes (0.5 to 1 µl) of the total cDNA plus sample, the remainder can thus safely be stored at -80˚C for any future analysis. By combining single-cell isolation with the characterization of defined TCR BV-CDR3 sequences, the TCR repertoire diversity and clonal composition of well-defined antigen-specific T cell subpopulations can also be characterized, and are in excellent agreement with the data obtained with large numbers of in vitro generated T cell clones (Fig. 3) . In the present study, we examined the expression of cell surface markers/receptors and cytoplasmic proteins known to be associated with either effector or memory/homing functions. IFNG, KLRD1, GZMB and PRF1 all encode for proteins well characterized to be expressed by effector CD8 pos T cells. 32, 40 Conversely, CD27 38 and IL7R properties. 50 In a different in vivo model, the microinjection of a single naive T cell was also shown to repopulate a host with a progeny of differentiated effector and memory cells. 51 These studies speak of the diversification potential of naive T cells, but yet do not address the polyfunctionality of individual cells. Single-cell based gene expression approaches were particularly successful in gaining insights in T cell heterogeneity and intrinsic polyfunctionality following primary antigenic stimulation or therapeutic vaccination. 20, 52 Our data are in line with these observations and further illustrate the increased level of diversity in terms of simultaneous co-expression of memory/homing-and effector-related genes, which we observed for both tumor-and virus-specific T cells, within defined subsets (EM28 pos and EM28 neg /EMRA) and specific TCR clonotypes (Fig. 5, Fig. 6 and Fig. 7 ).
Polyfunctional antigen-specific CD8 pos T cells have been commonly observed in response to viral diseases, both for acute (e.g. influenza) as well as for persistent but efficiently controlled (e.g. CMV and EBV) infections. Similarly, a higher degree of polyfunctionality was also described within a small group of HIV-infected individuals named long-term non-progressors compared to those with progressing HIV disease. 53, 54 It seems likely that protective T cell responses against viral infections or malignant diseases rely on both phenotypic and functional heterogeneity with a greater than ever polyfunctionality. Along these lines, Newell and coworkers 55 have very recently described a large degree of functional diversity even among Strikingly, memory/effector gene co-expression reflected a polyfunctionality that was also observed at the clonotypic level (Fig. 7 , data not shown), which may be important for mounting potent immune responses against tumors and pathogens.
Overall these data and those by others [58] [59] [60] show that a single amino acid substitution tested single-cell samples. *** 0.0001 < P < 0.001; ** 0.001 < P < 0.01; * 0.01 < P < 0.1; ns, not significant (by one-way ANOVA test). 
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